NENCETTI, SUSANNA Statistiche
NENCETTI, SUSANNA
DIPARTIMENTO DI FARMACIA
Omega-3 PUFAs as a Dietary Supplement in Senile Systemic Amyloidosis
2023-01-01 Ciccone, Lidia; Nencetti, Susanna; Rossello, Armando; Barlettani, Lucia; Tonali, Nicolò; Nieri, Paola; Orlandini, Elisabetta
Pomegranate: A Source of Multifunctional Bioactive Compounds Potentially Beneficial in Alzheimer’s Disease
2023-01-01 Ciccone, L.; Nencetti, S.; Rossello, A.; Orlandini, E.
Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway
2023-01-01 Montalesi, Emiliano; Cracco, Patrizio; Acconcia, Filippo; Fiocchetti, Marco; Iucci, Giovanna; Battocchio, Chiara; Orlandini, Elisabetta; Ciccone, Lidia; Nencetti, Susanna; Muzzi, Maurizio; Moreno, Sandra; Venditti, Iole; Marino, Maria
Antioxidant quercetin 3-O-glycosylated plant flavonols contribute to Transthyretin stabilization
2022-01-01 Ciccone, L.; Tonali, N.; Fruchart-Gaillard, C.; Barlettani, L.; Rossello, A.; Braca, A.; Orlandini, E.; Nencetti, S.
Compounds with a benzo [a]carbazole structure for use in the prevention and/or treatment of infectious diseases
2022-01-01 Rossello, Armando; Nencetti, Susanna; Nuti, Elisa; Orlandini, Elisabetta; Martini, Claudia; Costa, Barbara; Daniele, Simona; Giacomelli, Chiara; Ciccone, Lidia; Cuffaro, Doretta; Comar, Manola
Human transthyretin (TTR) complexed with Quercetin 3-O-beta-D-galactoside
2022-01-01 Ciccone, L.; Braca, A.; Orlandini, E.; Nencetti, S.
Nature-Inspired O-Benzyl Oxime-Based Derivatives as New Dual-Acting Agents Targeting Aldose Reductase and Oxidative Stress
2022-01-01 Ciccone, Lidia; Petrarolo, Giovanni; Barsuglia, Francesca; Fruchart-Gaillard, Carole; Cassar Lajeunesse, Evelyne; Adewumi, Adeniyi T; Soliman, Mahmoud E S; La Motta, Concettina; Orlandini, Elisabetta; Nencetti, Susanna
Pterostilbene fluorescent probes as potential tools for targeting neurodegeneration in biological applications
2022-01-01 Ciccone, Lidia; Nencetti, Susanna; Marino, Maria; Battocchio, Chiara; Iucci, Giovanna; Venditti, Iole; Marsotto, Martina; Montalesi, Emiliano; Socci, Simone; Bargagna, Beatrice; Orlandini, Elisabetta
Resveratrol-like Compounds as SIRT1 Activators
2022-01-01 Ciccone, L.; Piragine, E.; Brogi, S.; Camodeca, C.; Fucci, R.; Calderone, V.; Nencetti, S.; Martelli, A.; Orlandini, E.
Synthesis and Evaluation of Monoaryl Derivatives as Transthyretin Fibril Formation Inhibitors
2022-01-01 Ciccone, Lidia; Nencetti, Susanna; Camodeca, Caterina; Ortore, GABRIELLA MARIA PIA; Cuffaro, Doretta; Socci, Simone; Orlandini, Elisabetta
Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators
2021-01-01 Nocentini, A.; Cuffaro, D.; Ciccone, L.; Orlandini, E.; Nencetti, S.; Nuti, E.; Rossello, A.; Supuran, C. T.
Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs
2021-01-01 Tonali, Nicoló; Nencetti, Susanna; Orlandini, Elisabetta; Ciccone, Lidia
Carbonic anhydrase inhibitors and epilepsy: State of the art and future perspectives
2021-01-01 Ciccone, L.; Cerri, C.; Nencetti, S.; Orlandini, E.
Multifunctional Small Molecules as Potential Anti-Alzheimer's Disease Agents
2021-01-01 Bargagna, Beatrice; Ciccone, Lidia; Nencetti, Susanna; Amélia Santos, Maria; Chaves, Sílvia; Camodeca, Caterina; Orlandini, Elisabetta
Natural marine and terrestrial compounds as modulators of matrix metalloproteinases-2 (MMP-2) and MMP-9 in alzheimer’s disease
2021-01-01 Ciccone, L.; Vandooren, J.; Nencetti, S.; Orlandini, E.
Neuroglobin and neuroprotection: The role of natural and synthetic compounds in neuroglobin pharmacological induction
2021-01-01 Ciccone, L.; Nencetti, S.; Socci, S.; Orlandini, E.
Physiological metals can induce conformational changes in transthyretin structure: Neuroprotection or misfolding induction?
2021-01-01 Ciccone, L.; Tonali, N.; Shepard, W.; Nencetti, S.; Orlandini, E.
Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration
2020-01-01 Ortore, G.; Orlandini, E.; Betti, L.; Giannaccini, G.; Mazzoni, M. R.; Camodeca, C.; Nencetti, S.
Human transthyretin (TTR) complexed with (E)-3-(((3,5-dibromo-2-hydroxybenzylidene)amino)oxy)propanoic acid
2020-01-01 Ciccone, L.; Nencetti, S.; Orlandini, E.; Rossello, A.; Legrand, P.; Shepard, W.
Human transthyretin (TTR) complexed with (E)-3-(((4-hydroxybenzylidene)amino)oxy)propanoic acid
2020-01-01 Ciccone, L.; Shepard, W.; Nencetti, S.; Orlandini, E.; Rossello, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Omega-3 PUFAs as a Dietary Supplement in Senile Systemic Amyloidosis | 1-gen-2023 | Ciccone, Lidia; Nencetti, Susanna; Rossello, Armando; Barlettani, Lucia; Tonali, Nicolò; Nieri, Paola; Orlandini, Elisabetta | |
| Pomegranate: A Source of Multifunctional Bioactive Compounds Potentially Beneficial in Alzheimer’s Disease | 1-gen-2023 | Ciccone, L.; Nencetti, S.; Rossello, A.; Orlandini, E. | |
| Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway | 1-gen-2023 | Montalesi, Emiliano; Cracco, Patrizio; Acconcia, Filippo; Fiocchetti, Marco; Iucci, Giovanna; Battocchio, Chiara; Orlandini, Elisabetta; Ciccone, Lidia; Nencetti, Susanna; Muzzi, Maurizio; Moreno, Sandra; Venditti, Iole; Marino, Maria | |
| Antioxidant quercetin 3-O-glycosylated plant flavonols contribute to Transthyretin stabilization | 1-gen-2022 | Ciccone, L.; Tonali, N.; Fruchart-Gaillard, C.; Barlettani, L.; Rossello, A.; Braca, A.; Orlandini, E.; Nencetti, S. | |
| Compounds with a benzo [a]carbazole structure for use in the prevention and/or treatment of infectious diseases | 1-gen-2022 | Rossello, Armando; Nencetti, Susanna; Nuti, Elisa; Orlandini, Elisabetta; Martini, Claudia; Costa, Barbara; Daniele, Simona; Giacomelli, Chiara; Ciccone, Lidia; Cuffaro, Doretta; Comar, Manola | |
| Human transthyretin (TTR) complexed with Quercetin 3-O-beta-D-galactoside | 1-gen-2022 | Ciccone, L.; Braca, A.; Orlandini, E.; Nencetti, S. | |
| Nature-Inspired O-Benzyl Oxime-Based Derivatives as New Dual-Acting Agents Targeting Aldose Reductase and Oxidative Stress | 1-gen-2022 | Ciccone, Lidia; Petrarolo, Giovanni; Barsuglia, Francesca; Fruchart-Gaillard, Carole; Cassar Lajeunesse, Evelyne; Adewumi, Adeniyi T; Soliman, Mahmoud E S; La Motta, Concettina; Orlandini, Elisabetta; Nencetti, Susanna | |
| Pterostilbene fluorescent probes as potential tools for targeting neurodegeneration in biological applications | 1-gen-2022 | Ciccone, Lidia; Nencetti, Susanna; Marino, Maria; Battocchio, Chiara; Iucci, Giovanna; Venditti, Iole; Marsotto, Martina; Montalesi, Emiliano; Socci, Simone; Bargagna, Beatrice; Orlandini, Elisabetta | |
| Resveratrol-like Compounds as SIRT1 Activators | 1-gen-2022 | Ciccone, L.; Piragine, E.; Brogi, S.; Camodeca, C.; Fucci, R.; Calderone, V.; Nencetti, S.; Martelli, A.; Orlandini, E. | |
| Synthesis and Evaluation of Monoaryl Derivatives as Transthyretin Fibril Formation Inhibitors | 1-gen-2022 | Ciccone, Lidia; Nencetti, Susanna; Camodeca, Caterina; Ortore, GABRIELLA MARIA PIA; Cuffaro, Doretta; Socci, Simone; Orlandini, Elisabetta | |
| Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators | 1-gen-2021 | Nocentini, A.; Cuffaro, D.; Ciccone, L.; Orlandini, E.; Nencetti, S.; Nuti, E.; Rossello, A.; Supuran, C. T. | |
| Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs | 1-gen-2021 | Tonali, Nicoló; Nencetti, Susanna; Orlandini, Elisabetta; Ciccone, Lidia | |
| Carbonic anhydrase inhibitors and epilepsy: State of the art and future perspectives | 1-gen-2021 | Ciccone, L.; Cerri, C.; Nencetti, S.; Orlandini, E. | |
| Multifunctional Small Molecules as Potential Anti-Alzheimer's Disease Agents | 1-gen-2021 | Bargagna, Beatrice; Ciccone, Lidia; Nencetti, Susanna; Amélia Santos, Maria; Chaves, Sílvia; Camodeca, Caterina; Orlandini, Elisabetta | |
| Natural marine and terrestrial compounds as modulators of matrix metalloproteinases-2 (MMP-2) and MMP-9 in alzheimer’s disease | 1-gen-2021 | Ciccone, L.; Vandooren, J.; Nencetti, S.; Orlandini, E. | |
| Neuroglobin and neuroprotection: The role of natural and synthetic compounds in neuroglobin pharmacological induction | 1-gen-2021 | Ciccone, L.; Nencetti, S.; Socci, S.; Orlandini, E. | |
| Physiological metals can induce conformational changes in transthyretin structure: Neuroprotection or misfolding induction? | 1-gen-2021 | Ciccone, L.; Tonali, N.; Shepard, W.; Nencetti, S.; Orlandini, E. | |
| Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration | 1-gen-2020 | Ortore, G.; Orlandini, E.; Betti, L.; Giannaccini, G.; Mazzoni, M. R.; Camodeca, C.; Nencetti, S. | |
| Human transthyretin (TTR) complexed with (E)-3-(((3,5-dibromo-2-hydroxybenzylidene)amino)oxy)propanoic acid | 1-gen-2020 | Ciccone, L.; Nencetti, S.; Orlandini, E.; Rossello, A.; Legrand, P.; Shepard, W. | |
| Human transthyretin (TTR) complexed with (E)-3-(((4-hydroxybenzylidene)amino)oxy)propanoic acid | 1-gen-2020 | Ciccone, L.; Shepard, W.; Nencetti, S.; Orlandini, E.; Rossello, A. |